Aspirin-triggered lipid mediators
3 Assignments
0 Petitions
Accused Products
Abstract
Aspirin triggered lipid mediators (ATLMs) are disclosed which are useful for the treatment of prevention of inflammation associated with various diseases, including ischemia.
38 Citations
39 Claims
- 1. A compound having the formula:
- 4. A compound having the formula:
- 7. A compound having the formula:
- 9. A compound having the formula:
- 11. A method for treating or preventing inflammation in a subject, comprising the step of administering a combination of an omega-3 fatty acid and aspirin, such that inflammation is treated or prevented in the subject.
- 15. A method for treating arterial inflammation, arthritis, or cardiovascular diseases in a subject, comprising the step of administering to the subject a combination of an omega-3 fatty acid and aspirin, such that arterial inflammation, arthritis, or cardiovascular disease is treated or prevented in the subject.
-
19. A method for treating or preventing inflammation in a subject, comprising the step of administering to the subject a compound having the formula:
-
20. A method for treating or preventing inflammation in a subject, comprising the step of administering to the subject a compound having the formula:
-
21. A method for treating or preventing inflammation in a subject, comprising the step of administering to the subject a compound having the formula:
-
22. A method for treating or preventing inflammation in a subject, comprising the step of administering to the subject a compound having the formula:
-
23. A method for treating arterial inflammation, arthritis, or cardiovascular diseases in a subject, comprising the step of administering to the subject compound having the formula:
-
24. A method for treating arterial inflammation, arthritis, or cardiovascular diseases in a subject, comprising administering to the subject a compound having the formula:
-
25. A method for treating arterial inflammation, arthritis, or cardiovascular diseases in a subject, comprising administering to the mammal a compound having the formula:
-
26. A method for treating arterial inflammation, arthritis, or cardiovascular diseases in a subject, comprising administering to the mammal a compound having the formula:
-
27. A hydroxyl protected or unprotected monohydroxyl-docosahexaenoic acid or a pharmaceutically acceptable analogue thereof.
-
28. A compound having the formula:
-
29. A compound having the formula:
-
30. A compound having the formula:
-
31. A compound having the formula:
-
32. A compound having the formula:
-
33. A compound having the formula:
-
34. A method for treating or preventing inflammation in a subject, comprising the step of administering to the subject a compound having the formula:
-
35. A method for treating or preventing inflammation in a subject, comprising the step of administering to the subject a compound having the formula:
-
36. A method for treating or preventing inflammation in a subject, comprising the step of administering to the subject a compound having the formula:
-
37. A method for treating or preventing inflammation in a subject, comprising the step of administering to the subject a compound having the formula:
-
38. A method for treating or preventing inflammation in a subject, comprising the step of administering to the subject a compound having the formula:
-
39. A method for treating or preventing inflammation in a subject, comprising the step of administering to the subject a compound having the formula:
Specification